The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine safety and tolerance of administering aerosolized recombinant interferon gamma
(IFN-gamma) for 4 weeks in patients with AIDS. To examine activation of alveolar macrophages
by aerosolized IFN-gamma administration. To determine if subcutaneous (SC) injection of
IFN-gamma can activate alveolar macrophages in AIDS patients.